minutemd semaglutide Micro-Dose Program (Three Months) optimize results Semaglutide – julymd

Semaglutide is a GLP-1 receptor agonist peptide medication prescribed for type 2 diabetes management

Without continued treatment or significant lifestyle changes, the appetite suppression effect ends when the medication does

For a complete breakdown of what to avoid, see our guide on foods to avoid during GLP-1 treatment , which applies equally to semaglutide

Are syringes included

After several months at a stable dose, most people find side effects minimal or absent

This guide explains how to adapt your eating habits to support comfort, safety, and nutritional adequacy throughout retatrutide treatment, in line with UK clinical guidance